SCHEMBL17617892

SCHEMBL17617892

CNC(=O)CC(NC)C(C)=O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.34
LMNA P02545 1/20 0.34
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29335435 0.82 MMP2 (0.36)
SCHEMBL13035653 0.82
SCHEMBL27475433 0.82 MCL1 (0.32) MCL1LMNAATM
SCHEMBL24379707 0.82
SCHEMBL13258521 0.81 MMP2 (0.40) MCL1LMNAATM
SCHEMBL277484 0.81 ATM (0.37) MCL1LMNAATM
SCHEMBL14184587 0.80 MCL1 (0.38) MCL1
SCHEMBL13525020 0.80 MEN1 (0.38) LMNA
SCHEMBL13474987 0.80 ALDH1A1 (0.43)
SCHEMBL12157037 0.80 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238459-A1 Granzyme-Activatable Membrane-Interacting Peptides and Methods of Use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-07-18 US disclosed
US-11712483-B2 Activatable membrane-interacting peptides and methods of use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-08-01 US disclosed
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
US-9789209-B2 Activatable membrane-interacting peptides and methods of use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE (US) 2017-10-17 US disclosed
US-20160082131-A1 Activatable Membrane-Interacting Peptides and Methods of Use THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11712483-B2 Activatable membrane-interacting peptides and methods of use ANXA5, PLA2G2A, F13B MCL1 320/4885LMNA 108/4885ATM 3968/4885
US-20240238459-A1 Granzyme-Activatable Membrane-Interacting Peptides and Methods of Use GZMB, PRF1, PLA2G2A MCL1 454/4885LMNA 498/4885ATM 4408/4885
US-20160082131-A1 Activatable Membrane-Interacting Peptides and Methods of Use ANXA5, PLA2G2A, F13B MCL1 320/4885LMNA 108/4885ATM 3968/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 MCL1 2299/4885LMNA 826/4885ATM 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.